Rheumatic Immune-related Adverse Events Associated with Immune Checkpoint Inhibitors for Cancer: Coming soon to a clinic near you.

CRAJ 2018
An overview of rheumatologic immune-related adverse events associated with immune checkpoint inhibitors, along with a case description of inflammatory polyarthritis developing after initiation of pembrolizumab for the treatment of metastatic non-small cell lung cancer.

Ye C, Jamal S, Hudson M.  CRAJ 2018: